{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:30:41Z","timestamp":1793136641961,"version":"4.5.0"},"reference-count":37,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T00:00:00Z","timestamp":1380499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:p>\n                    Although oral iron is the initial treatment approach for iron deficiency anemia (IDA), some patients fail to respond to or cannot tolerate oral iron. This double\u2010blind safety and efficacy study of the intravenous (IV) iron, ferumoxytol, randomized patients with a history of unsatisfactory oral iron therapy, or in whom oral iron could not be used, to ferumoxytol (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009609) or placebo (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009203). The proportion of patients achieving the primary endpoint (hemoglobin increase \u22652.0 g\/dL at Week 5) was 81.1% with ferumoxytol versus 5.5% with placebo (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.0001). The mean increase in hemoglobin from Baseline to Week 5, a secondary endpoint (also the alternative preplanned primary efficacy endpoint for other health authorities), was 2.7 versus 0.1 g\/dL (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.0001). Achievement of a hemoglobin \u226512 g\/dL, time to a hemoglobin increase \u22652.0 g\/dL, and improvement in the Functional Assessment of Chronic Illness Therapy Fatigue score also significantly favored ferumoxytol over placebo at Week 5 (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.0001). Ferumoxytol treatment\u2010emergent adverse events were mainly mild to moderate. Ferumoxytol was effective and well tolerated in patients with IDA of any underlying cause in whom oral iron was ineffective or could not be used. This trial was registered at\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.clinicaltrials.gov\">www.clinicaltrials.gov<\/jats:ext-link>\n                    as #NCT01114139. Am. J. Hematol. 89:7\u201312, 2014. \u00a9 2013 Wiley Periodicals, Inc.\n                  <\/jats:p>","DOI":"10.1002\/ajh.23582","type":"journal-article","created":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T05:33:10Z","timestamp":1377495190000},"page":"7-12","source":"Crossref","is-referenced-by-count":64,"title":["Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron"],"prefix":"10.1002","volume":"89","author":[{"given":"Saroj","family":"Vadhan\u2010Raj","sequence":"first","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Strauss","sequence":"additional","affiliation":[{"name":"AMAG Pharmaceuticals, Inc. Lexington Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ford","sequence":"additional","affiliation":[{"name":"Toronto Digestive Disease Associates, Inc. Vaughan Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Bernard","sequence":"additional","affiliation":[{"name":"AMAG Pharmaceuticals, Inc. Lexington Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Boccia","sequence":"additional","affiliation":[{"name":"The Center for Cancer and Blood Disorders Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Li","sequence":"additional","affiliation":[{"name":"AMAG Pharmaceuticals, Inc. Lexington Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee F.","family":"Allen","sequence":"additional","affiliation":[{"name":"AMAG Pharmaceuticals, Inc. Lexington Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,9,30]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.13255"},{"key":"e_1_2_8_3_1","first-page":"1","volume-title":"Worldwide prevalence of anaemia 1995\u20132005","author":"World Health Organization","year":"2008"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmh705"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/10.1.40"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32834f3140"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21740"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i36.4798"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008978114650"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.2000.88.3.1103"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/131.2.676S"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.035758"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00396-X"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh235"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1778-428X.2007.00060.x"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01744.x"},{"key":"e_1_2_8_17_1","first-page":"697S","article-title":"Iron\u2010deficiency anemia: Reexamining the nature and magnitude of the public health problem","volume":"131","author":"Stoltzfus RJ","year":"2001","journal-title":"Summary: Implications for research and programs. J Nutr"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02840608"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X100096"},{"key":"e_1_2_8_20_1","volume-title":"Dexferrum [package insert]","year":"2009"},{"key":"e_1_2_8_21_1","volume-title":"INFed Prescribing Information","year":"2009"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc070203"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.2165\/11209880-000000000-00000"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.11.31"},{"key":"e_1_2_8_25_1","first-page":"473","article-title":"The MOS 36\u2010item short\u2010form health survey (SF\u201036)","volume":"30","author":"Ware JE","year":"1992","journal-title":"I. Conceptual framework and item selection. Med Care"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh185"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21794"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22153"},{"key":"e_1_2_8_29_1","unstructured":"MacDougallIC McGlaughlinJ FortinGS et al.FIRST: Head\u2010to\u2010head comparison study (Ferumoxytol compared to IRon Sucrose Trial) of the safety and efficacy of ferumoxytol with iron sucrose for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD). Presented at the American Society of Nephrology 44th annual meeting2011 Philadelphia PA USA 2011."},{"key":"e_1_2_8_30_1","unstructured":"RawalA KatsulisP StutzL et al.Comparison of intravenous iron therapy for the treatment of anemia in CKD. Presented at the National Kidney Foundation Spring Meeting (SCM13)2013 Orlando FL USA 2013."},{"key":"e_1_2_8_31_1","unstructured":"MeyersM ErdalE KhanC et al.Efficiency outcomes associated with increased ferumoxytol use in an infusion clinic. Presented at the American Society of Health System Pharmacists Midyear Clinical Meeting2011 New Orleans LA USA. Poster No. 5\u2010004. 2011."},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(02)00529-8"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(02)00628-7"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X178757"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.MLR.0000062554.74615.4C"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007101156"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00598.x"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.08.001"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.23582","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.23582","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ajh.23582","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.23582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T11:34:38Z","timestamp":1696592078000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.23582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,30]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.1002\/ajh.23582"],"URL":"https:\/\/doi.org\/10.1002\/ajh.23582","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,30]]}}}